Use of canabidiol as a treatment alternative for alzheimer's: a literature review

Autores/as

  • João Vitor Martins da Silva
  • Romana Rodrigues Andrade Reis
  • Luíza Madureira Silva
  • Dara da Silva Mesquita
  • José Eduardo Ribeiro Honório Júnior

Palabras clave:

Cannabidiol, Alzheimer's disease, Neurotoxicology, Neurology, Receivers

Resumen

Alzheimer's disease is a neurodegenerative disease in which progressive memory loss occurs and presents cognitive symptoms.  Currently, the number of studies with Cannabidiol as a treatment alternative for Alzheimer's disease is growing due to its neuroprotective factor. Research indicates that cannabidiol has the ability to control microglial and neuroinflammation function, favoring the survival rate of cells by combining its anti-inflammatory, antioxidant and neuroprotective effects, which act against toxicity caused by the accumulation of beta-amyloid peptides.

 

DOI: https://doi.org/10.56238/tfisdwv1-128

Descargas

Publicado

2023-04-13

Número

Themes focused on interdisciplinarity and sustainable development worldwide V.1

Sección

Articles

Licencia

Derechos de autor 2023 João Vitor Martins da Silva, Romana Rodrigues Andrade Reis, Luíza Madureira Silva, Dara da Silva Mesquita, José Eduardo Ribeiro Honório Júnior

Creative Commons License

Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-SinDerivadas 4.0.

Cómo citar

Use of canabidiol as a treatment alternative for alzheimer’s: a literature review. (2023). Seven Editora. https://sevenpublicacoes.com.br/editora/article/view/941